Dr. Elizabeth Reed Aden, a PHD and a former pharma industry executive and the author of The Goldilock Genome joins eHealth Radio and the Health News and Pharmaceutical Channels. Listen to interview with host Eric Michaels & guest Dr. Elizabeth Reed Aden discuss the following:

1. You wrote your book, The Goldilocks Genome, based on your experiences in the pharmaceutical industry. What is it about?
2. What is "the Goldilocks effect" in prescription drugs?
3. Why are you a champion of personalized medicine?
4. Name a few examples of how knowing our personal genetics can help us make better choices in food and medication?
5. What do you want your readers to take away from your book?  

Elizabeth Reed Aden, PhD earned her doctorate in biomedical anthropology from the University of Pennsylvania. After conducting extensive epidemiology and serology studies and teaching as an Assistant Professor at the University of Illinois, Urbana-Champaign, she began her career in the pharmaceutical industry, where she rose to be Senior Vice President for Global Pharmaceutical Strategy at a major Swiss pharmaceutical company. After leaving Big Pharma, she held leadership positions in various biotechnology companies, founded and co-founded biotech companies, consulted for a wide range of clients, and served on Boards of Directors. Since 2017, she has brought multiple previously unpublished cozy murder mysteries written by her godmother, Eunice Mays Boyd, to print, among them Dune House, Slay Bells, and A Vacation to Kill For. The Goldilocks Genome is Elizabeth’s debut medical thriller. She is currently working on a memoir, Hepatitis Beach, which she hopes to have published by 2025. She lives in Berkeley, California. Website: https://elizabethreedaden.com Social Media Links: Instagram: https://www.instagram.com/elizabeth_r_aden   Facebook: https://www.facebook.com/ElizabethReedAden   Twitter: https://twitter.com/eliz_reed_aden  People also listened to this: Breast Implant Illness & Implant Removal with Dr. Sayed